Literature DB >> 1679869

Reaction of human non-collagenous polypeptides with coeliac disease autoantibodies.

M Mäki1, O Hällström, A Marttinen.   

Abstract

We identified and purified six human noncollagenous protein molecules that specifically bind to serum IgA from patients with coeliac disease, and which as a combination can act as true antigen to reticulin antibodies. In affinity chromatography, the purified human protein molecules removed antibodies against reticulin and endomysium from serum samples of coeliac disease patients. We postulate that an autoimmune mechanism operates in generating the jejunal damage in gluten-sensitive enteropathy and that the human protein molecules described here act as self-antigens in the disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679869     DOI: 10.1016/0140-6736(91)91445-z

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

1.  B cell epitopes of gliadin.

Authors:  A A Osman; T Günnel; A Dietl; H H Uhlig; M Amin; B Fleckenstein; T Richter; T Mothes
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Coeliac disease: A review of the causative agents and their possible mechanisms of action.

Authors:  H J Cornell
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

3.  Phenotypical characterization of peripheral blood T cells in patients with coeliac disease: elevation of antigen-primed CD45RO+ T lymphocytes.

Authors:  T O Kerttula; O Hällström; M Mäki
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

4.  ACP Broadsheet No 149: September 1996. Serological diagnosis of gluten sensitive enteropathy.

Authors:  D J Unsworth
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

5.  Serum IgA anti-gliadin antibodies in an adult population sample. High prevalence without celiac disease.

Authors:  O Uibo; R Uibo; V Kleimola; T Jõgi; M Mäki
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

6.  Partial seizures, cerebral calcifications and celiac disease.

Authors:  A Cernibori; G Gobbi
Journal:  Ital J Neurol Sci       Date:  1995-04

7.  IgA antibodies to jejunum. Specific immunity directed against target organ of gluten-sensitive enteropathy.

Authors:  U Volta; N Molinaro; D Fratangelo; F B Bianchi
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.